Efficacy and safety of ciprofol for gastroscopy in patients with obesity: a randomised clinical controlled trial using different weight-based dosing scales

Table 3 Remedial sedation conditions, drug dosage, recovery time, time to restore directional force, and PACU residence time

	Group T (n = 36)	Group I (n = 38)	Group L (n = 34)	P value
Remedial sedation, n (%)				0.010*
Yes, n (%)	12 (33.33)	20 (52.63)	27 (79.41)^a
No, n (%)	24 (66.67)	18 (47.37)	7 (20.59)^a
Frequency of remedial sedation (times)	0.42 ± 0.65	0.53 ± 0.51	0.94 ± 0.60^ab	< 0.001*
Total dose of ciprofol (mg)	40.32 ± 11.36	33.07 ± 7.57^a	34.89 ± 7.93^a	0.003*
Recovery time (min)	5.47 ± 3.86	5.47 ± 3.33	5.79 ± 3.50	0.910
Time to restore directional force (min)	4.64 ± 2.55	3.50 ± 1.35	3.97 ± 1.55	0.054
PACU residence time (min)	20.67 ± 4.13	19.95 ± 3.00	19.26 ± 2.34	0.202

Note: Data are presented as the mean ± standard deviation or n (%). Frequency data (percentages) were analysed using the Pearson chi-square test. For multiple comparisons, Bonferroni correction was performed to determine the p value significance threshold. Other data were analysed using analysis of variance for comparisons between groups, and the least significant difference test was used for pairwise comparisons. PACU, post anaesthesia care unit
*P < 0.05
^aP<0.016 compared to Group T
^bP<0.016 compared to Group I

ISSN: 1471-2253